On Friday, Following U.S. Stocks were among the “Top Gainers“: Sprint Corp (NYSE:S), Plug Power Inc (NASDAQ:PLUG), Ruckus Wireless Inc (NYSE:RKUS), ZIOPHARM Oncology Inc (NASDAQ:ZIOP)
Sprint Corp (NYSE:S)’s shares picked up 0.39%, and closed at $5.12. The stock volatility for the week is 3.17%, while for the month remained 4.04%. The company holds consensus target price of $7.28.
If we consider EPS growth of the company, then we will notice the following observations:
The company showed -0.83 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 92.60%, and Annual EPS growth for the past 5 years is considered as -73.48%.
The mean recommendation of analysts for this stock is 2.70. (where 1=Buy, 5=Sale).
Sprint Corporation provides wireless and wireline communications services to consumers, businesses, and government users in the United States, Puerto Rico, and the U.S. Virgin Islands. It operates in two segments, Wireless and Wireline. The Wireless segment offers wireless data communication services, counting mobile productivity applications, such as Internet access, messaging, and email services; wireless photo and video offerings; location-based capabilities comprising asset and fleet administration, dispatch services, and navigation tools; mobile entertainment applications; and local and long distance wireless voice services, in addition to voicemail, call waiting, three-way calling, caller identification, directory assistance, and call forwarding services.
Plug Power Inc (NASDAQ:PLUG), raised 2.88%, and closed at $2.86. The company holds the market capitalization of 495.14M. For the trailing twelve months, the stock’s return on equity value remains -122.00%, while return on assets value is -78.50%, in response to its return on investment value of 172.30%. Its 20-day moving average declined -6.24%, below 50-day moving average of -3.57%, above 200-day moving average of -31.39% from the latest market price of $2.86. The mean recommendation of analysts for this stock is 2.00.(where 1=Buy, 5=Sale).
Plug Power Inc., an alternative energy technology provider, is engaged in the design, development, manufacture, and commercialization of fuel cell systems for the industrial off-road markets worldwide. It is focused on proton exchange membrane (PEM) fuel cell and fuel processing technologies and fuel cell/battery hybrid technologies. The company’s product line comprises GenDrive, a hydrogen fueled PEM fuel cell system providing power to material handling vehicles; GenKey, its turn-key solution offering simplicity to customers transitioning their material handling vehicles to fuel cell power; GenFuel, its hydrogen fueling delivery system; and GenCare, its ongoing maintenance program for both the GenDrive fuel cells and GenFuel products.
Ruckus Wireless Inc (NYSE:RKUS), enhanced 2.77%, and closed at $12.63. The stock has price to sale value of 3.29, however, price to book value is 4.11. With recent incline, the year-to-date (YTD) performance reflected a 5.07% gain above last year. During the past month the stocks lose -4.54%, bringing three-month performance to 16.08% and six-month performance to -16.52%. The mean recommendation of analysts for this stock is 2.00. (where 1=Buy, 5=Sale).
Ruckus Wireless, Inc. provides carrier-class Wi-Fi solutions to service providers and enterprises worldwide. It provides gateways, controllers, and access points with related software and services. The company offers SmartCell, a line of carrier-grade wireless access and administration products that comprise specialized hardware products, such as SmartCell Gateways and SmartCell Access Points, in addition to software solutions comprising virtualized SmartCell Gateway and SmartCell Insight software platforms.
ZIOPHARM Oncology Inc (NASDAQ:ZIOP), rose 2.70%, and closed at $ 13.32. The stock has the beta value of 1.79, and its volatility for the week is 7.29%, while for the month it is 7.63%. The company has the market capitalization of $ 1.53B. The company holds the book value per share of 0.33, whereas cash per share is 0.37. Price to book value is estimated to be 40.36, while price to sale value is 1091.19. Analysts mean recommendation for the stock is said to be 2.30 (where 1=Buy, 5=sale).
ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing cancer therapies. The company is employing novel gene expression, and control and cells technologies to deliver cell-based therapies for the treatment of cancer. Its technology platform employs Intrexon Corporation’s RheoSwitch Therapeutic System technology to turn on and off, and precisely modulate, gene expression at the cancer site in order to improve the therapeutic index.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
